From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?
Molecules · 28.06.2023 · 28 (13) · 5052
DOI: 10.3390/molecules28135052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 28.06.2023. Verfasst von Mu Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou 350122, China. Hauptthemen laut MEDLINE: Thiazoles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Initiation Fund of Fujian Medical University, Fujian University Industry University Cooperation Project, Fujian University-Industry Cooperation Project.
Abstract (Originalsprache)
Imidazothiazole derivatives are becoming increasingly important in therapeutic use due to their outstanding physiological activities. Recently, applying imidazothiazole as the core, researchers have synthesized a series of derivatives with biological effects such as antitumor, anti-infection, anti-inflammatory and antioxidant effects. In this review, we summarize the main pharmacological effects and pharmacological mechanisms of imidazothiazole derivates; the contents summarized herein are intended to advance the research and rational development of imidazothiazole-based drugs in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fujian Medical University, Fuzhou 350122, China.
- Fujian Center for New Drug Safety Evaluation, Fuzhou 350122, China.
- School of Pharmacy, Macau University of Science and Technology, Macau 999078, China.
ORCID-Profile: Mu Guo, Yi Zhun Zhu, Yue Yu
Förderung
- Scientific Research Initiation Fund of Fujian Medical University
- Fujian University Industry University Cooperation Project
- Fujian University-Industry Cooperation Project
Zitieren
APA
Guo, M., Yu, X., Zhu, Y. Z., & Yu, Y. (2023). From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?. Molecules, 28(13), 5052. https://doi.org/10.3390/molecules28135052
Vancouver
Guo M, Yu X, Zhu YZ, Yu Y. From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?. Molecules. 2023;28(13):5052. doi:10.3390/molecules28135052
BibTeX
@article{Guo2023,
author = {Guo, Mu and Yu, Xiangbin and Zhu, Yi Zhun and Yu, Yue},
title = {From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?},
journal = {Molecules},
year = {2023},
volume = {28},
number = {13},
pages = {5052},
doi = {10.3390/molecules28135052}
}
EUVIMED